vaccine
Letters: The limitations of a Covid vaccine
Still distant Sir: In James Forsyth’s analysis (‘Boris’s booster shot’, 14 November) he infers that a vaccine, if provided to…
The dangers of censoring anti-vaxxers
Earlier this week, the Labour party wrote to the government urging it to bring forward legislation so that social media…
There's nothing wrong with profiting from a vaccine
A couple of shots to the arm and this will all be over. With today’s news from Moderna, last week’s…
Open and shut case: how did lockdown affect shops?
Shot in the arm Global stock markets reached a new high after pharmaceutical firm Pfizer announced a vaccine it is…
The questions we must ask about the Covid vaccine
The Covid vaccine still has a long way to go
Will the vaccine revive Boris?
The first full week of the new national lockdown had the potential to be very difficult for Boris Johnson. Although…
Portrait of the week: Vaccine hopes up, Zoom shares down and Biden calls Boris
Home Pfizer and BioNTech announced a vaccine against Covid-19 of 90 per cent efficacy from two injections three weeks apart.…
Will the Pfizer vaccine live up to the hype?
So is this the big turning point? Markets certainly seem to think so. No sooner had news broken that the…
What I learnt as an Oxford vaccine guinea pig
Was the Oxford vaccine trial paused? Mine wasn’t. I signed up for it last week, in the 55 to 69-year-old…
The vaccine goalposts have shifted
British Health Secretary Matt Hancock provided a vaccine update this morning London time, reporting that the chances of the Oxford…
Will the speculative vaccine shopping spree ever end?
Somewhere, possibly in the land of big sheds, just off the M1 in Leicestershire, must be a burgeoning NHS surplus…
One hundred years on, could we cope with a new flu pandemic?
Do you remember the swine flu panic a decade ago? Jeremy Brown, the author of this book, describes it here.…
